Granted Patent
B2
US 8,962,638 · App. 13/627,747 · Granted Feb 24, 2015
Piperidine inhibitors of janus kinase 3
Assignee:
Auspex Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.
Claims (3)
1. A method of treatment of a disorder selected from the group consisting of renal transplant rejection, rheumatoid arthritis, psoriasis, inflammatory bowel disease, dry eye syndrome, asthma, and transplant rejection comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula
or a pharmaceutically acceptable salt thereof.
2. The method as recited in claim 1 wherein said disorder is rheumatoid arthritis.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 12, 2013
From: RAO, TADIMETI; ZHANG, CHENGZHI
To: AUSPEX PHARMACEUTICALS
Reel/Frame 029794/0321 →
Continuity (4)
Provisional Application
61300887
· Feb 3, 2010
Provisional Application
61170858
· Apr 20, 2009